Gene · 962
Papers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,301 to 1,320 of 3,378
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications. | Int J Mol Sci | 2021 | 34206399 | PubTator, text mining | PubMed |
| Maternal Immune System and State of Inflammation Dictate the Fate and Severity of Disease in Preeclampsia. | J Immunol Res | 2021 | 34195300 | PubTator, text mining | PubMed |
| Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions. | Cancer Cell Int | 2021 | 34193146 | PubTator, text mining | PubMed |
| Post-myocardial infarction heart failure dysregulates the bone vascular niche. | Nat Commun | 2021 | 34172720 | PubTator, text mining | PubMed |
| CD58 Immunobiology at a Glance. | Front Immunol | 2021 | 34168659 | PubTator, text mining | PubMed |
| Gene Expression Profiling of Lymph Node Sub-Capsular Sinus Macrophages in Cancer. | Front Immunol | 2021 | 34168645 | PubTator, text mining | PubMed |
| CXCL10 potentiates immune checkpoint blockade therapy in homologous recombination-deficient tumors. | Theranostics | 2021 | 34158843 | PubTator, text mining | PubMed |
| The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response. | NPJ Precis Oncol | 2021 | 34158591 | PubTator, text mining | PubMed |
| Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma. | Aging (Albany NY) | 2021 | 34158412 | PubTator, text mining | PubMed |
| Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study. | Respir Res | 2021 | 34158044 | PubTator, text mining | PubMed |
| Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domain. | Nat Chem Biol | 2021 | 34155404 | PubTator, text mining | PubMed |
| Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm. | Exp Hematol | 2021 | 34153382 | PubTator, text mining | PubMed |
| Circulating and Tumor-Infiltrating NK Cells From Clear Cell Renal Cell Carcinoma Patients Exhibit a Predominantly Inhibitory Phenotype Characterized by Overexpression of CD85j, CD45, CD48 and PD-1. | Front Immunol | 2021 | 34149719 | PubTator, text mining | PubMed |
| COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. | JCI Insight | 2021 | 34143756 | PubTator, text mining | PubMed |
| Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions. | Clin Pharmacol Ther | 2021 | 34143437 | PubTator, text mining | PubMed |
| Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy. | NPJ Precis Oncol | 2021 | 34135436 | PubTator, text mining | PubMed |
| Effect of increased blood flow rate on renal anemia and hepcidin concentration in hemodialysis patients. | BMC Nephrol | 2021 | 34126941 | PubTator, text mining | PubMed |
| Investigation of the Mechanism of Complement System in Diabetic Nephropathy via Bioinformatics Analysis. | J Diabetes Res | 2021 | 34124269 | PubTator, text mining | PubMed |
| Logical modelling of in vitro differentiation of human monocytes into dendritic cells unravels novel transcriptional regulatory interactions. | Interface Focus | 2021 | 34123352 | PubTator, text mining | PubMed |
| Exploring the Pathogenesis of Psoriasis Complicated With Atherosclerosis via Microarray Data Analysis. | Front Immunol | 2021 | 34122426 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/962/papers?page=66